Literature DB >> 7882367

Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade human glioma.

S W Coons1, P C Johnson, J R Shapiro.   

Abstract

This study combined flow cytometry with standard cytogenetic analysis of first division cells to evaluate regional heterogeneity in 38 spatially mapped regions of a low grade human oligoastrocytoma. Histologically, the tumor was relatively homogeneous. In contrast, flow cytometry and cytogenetic analyses identified variable percentages of near-diploid (ND; 35 to 57 chromosomes/metaphase) and near-tetraploid (81-103 chromosomes/metaphase) populations. The largest proportion of cells in the ND population was 46,XY with normal Giemsa bands; however, four karyotypically unrelated ND clones also were identified. The development of these clonal populations centered around a region in which more than 50% of the cells contained nonclonal abnormalities and which demonstrated more histological pleomorphism than any other region. The frequency of the nonclonal karyotypes suggested that this region was genetically unstable. Three of the clonal ND populations resided in small, spatially discreet areas of the tumor. The largest and the most widely distributed clonal population, 47,XY,+7, underwent further evolution to give rise to seven additional sidelines. This investigation demonstrates that low grade gliomas have areas of genetic instability capable of generating mutant cells with the capacity to proliferate and to form cellular foci. As a result, multiple, spatially distinct clonal populations can exist in low grade gliomas, some of which are capable of further cytogenetic evolution and clonal expansion, resulting in tumor progression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7882367

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

Review 1.  "...those left behind." Biology and oncology of invasive glioma cells.

Authors:  M E Berens; A Giese
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  Extensive intra-tumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations.

Authors:  A Misra; P Chattopadhyay; A K Dinda; C Sarkar; A K Mahapatra; S E Hasnain; S Sinha
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

3.  Tracing the tumor lineage.

Authors:  Nicholas E Navin; James Hicks
Journal:  Mol Oncol       Date:  2010-05-05       Impact factor: 6.603

Review 4.  Molecular heterogeneity of glioblastoma and its clinical relevance.

Authors:  Katalin Eder; Bernadette Kalman
Journal:  Pathol Oncol Res       Date:  2014-08-27       Impact factor: 3.201

Review 5.  Genetic and non-genetic clonal diversity in cancer evolution.

Authors:  James R M Black; Nicholas McGranahan
Journal:  Nat Rev Cancer       Date:  2021-03-16       Impact factor: 60.716

6.  Label-free direct electronic detection of biomolecules with amorphous silicon nanostructures.

Authors:  John Lund; Ranjana Mehta; Babak A Parviz
Journal:  Nanomedicine       Date:  2006-12       Impact factor: 5.307

7.  Multimodal MR imaging model to predict tumor infiltration in patients with gliomas.

Authors:  Christopher R Durst; Prashant Raghavan; Mark E Shaffrey; David Schiff; M Beatriz Lopes; Jason P Sheehan; Nicholas J Tustison; James T Patrie; Wenjun Xin; W Jeff Elias; Kenneth C Liu; Greg A Helm; A Cupino; Max Wintermark
Journal:  Neuroradiology       Date:  2013-12-15       Impact factor: 2.804

8.  Lectin histochemistry of astrocytic tumors and in vitro characterization of lectin-induced modifications on the proliferation of the SW1088, U373 and U87 human astrocytic cell lines.

Authors:  I Camby; I Salmon; R De Decker; J L Pasteels; J Brotchi; A Danguy; R Kiss
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

9.  Tumour heterogeneity in the clinic.

Authors:  Philippe L Bedard; Aaron R Hansen; Mark J Ratain; Lillian L Siu
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

Review 10.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.